Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
| The first 150 words of the full text of this article appear below. |
EDITOR
Lidegaard is mistaken in his commentary on the MICA study of
oral contraceptives and myocardial infarction.1 Third generation oral contraceptives were, in fact, preferentially prescribed to women at lower risk of myocardial infarction. The odds ratios of
third versus second generation pills increased rather than decreased
when more potential confounders were entered into the logistic
model.1 Similar preferential prescribing in favour of
third generation contraceptives was found in the only empirical study
of prescribing in the United Kingdom.2
The MICA study should now lay to rest the lipid hypothesis of oral
contraceptives and myocardial infarction, which was influential in the
massive shift in prescribing to third generation pills (which have less
effect on blood lipid concentrations) in the early 1990s. Angiography
after myocardial infarction has shown that oral contraceptive users
have little atherosclerosis, which is consistent with repeated
epidemiological findings that past use of oral contraceptives does not